JEPI vs SCHA
JPMorgan Equity Premium Income ETF vs Schwab US Small-Cap ETF
- • SCHA has the lower expense ratio at 0.03% vs 0.35% for JEPI.
- • JEPI pays a higher dividend yield (7.93%).
Side-by-side metrics
| Metric | JEPI | SCHA |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.03% |
Dividend yield Trailing 12-month yield. | 7.93% | 1.12% |
AUM Assets under management — bigger funds are typically more liquid. | $46.16B | $22.04B |
YTD return | 7.47% | 18.09% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.40 | 1.23 |
P/E ratio | 24.39 | 16.37 |
Last price | $58.17 | $33.55 |
Inception | — | — |
Issuer | JPMorgan | Schwab |
JEPI top holdings
| MA | Mastercard Inc Class A | 1.96% |
| AAPL | Apple Inc | 1.94% |
| MSFT | Microsoft Corp | 1.94% |
| V | Visa Inc Class A | 1.86% |
| NEE | NextEra Energy Inc | 1.80% |
| JNJ | Johnson & Johnson | 1.80% |
| EOG | EOG Resources Inc | 1.78% |
| MMM | 3M Co | 1.78% |
| JIMXX | JPMorgan Prime Money Market IM | 1.76% |
| ABBV | AbbVie Inc | 1.76% |
SCHA top holdings
| HALO | Halozyme Therapeutics Inc | 0.36% |
| GKOS | Glaukos Corp | 0.34% |
| W | Wayfair Inc Class A | 0.32% |
| BMNR | BitMine Immersion Technologies Inc | 0.29% |
| AHR | American Healthcare REIT Inc Ordinary Shares | 0.28% |
| BTSG | BrightSpring Health Services Inc | 0.27% |
| R | Ryder System Inc | 0.26% |
| VSAT | Viasat Inc | 0.26% |
| ENSG | Ensign Group Inc | 0.25% |
| WTFC | Wintrust Financial Corp | 0.25% |
About JEPI
JEPI (JPMorgan Equity Premium Income ETF) is Active equity income with covered-call overlay. Managed by JPMorgan, the fund carries $46.2B in assets under management, an expense ratio of 0.35%, a dividend yield of 7.93%. Its largest holding is Mastercard Inc Class A (MA), which represents 2.0% of the portfolio. Real Estate is the fund's largest sector exposure at 2.3%.
About SCHA
SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $22.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.12%. Its largest holding is Halozyme Therapeutics Inc (HALO), which represents 0.4% of the portfolio. Real Estate is the fund's largest sector exposure at 6.9%.